Bruker Corporation (Nasdaq: BRKR) today announced new updates from Bruker Spatial Biology to be showcased at the 2026 ...
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it will showcase its oncology workflow applications at the American Association for Cancer Research (AACR) Annual Meeting 2026 ...
Caris POA members advance precision medicine through collaborative research aimed at improving clinical outcomes for cancer ...
4don MSN
Pain-sensing neurons mapped in unprecedented detail, pointing to new chronic pain drug targets
One in five people worldwide suffers from chronic inflammatory pain. Meanwhile, about two thirds of those affected find ...
Tape-strip RNA sequencing identifies shared Th17/Th22 upregulation and epidermal differentiation complex activation across ...
Qlucore, listed on Nasdaq First North, announces the launch of a new Qlucore Insights test (Research Use Only) specifically developed for Acute Myeloid Leukemia (AML). The software-based test delivers ...
New program matches top researchers with expert service providers trained to offer a comprehensive suite of Shasta® ...
A long-standing belief about HIV has quietly shaped how scientists think about the virus. For decades, researchers described ...
In this conference report from ABRF 2026, the authors reflect on the meeting's insights into core facility research and ...
A375, HEK293T, Sk-Mel-3 and Sk-Mel-24 cell lines were obtained from the American Type Culture Collection. A375 and HEK293T cells were maintained in ...
Precision Medicine Online's seventh annual survey shows precision oncology programs didn't go unscathed as the Trump administration slashed research funding and canceled projects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results